Enterprise Value to EBITDA Multiple ratio Analysis of Novo Nordisk A/S - Deep Dive
Latest FY EV to EBITDA
Period Ending - Dec-23
Very Good EV to EBITDA
5.46
Period Ending - Dec-22
Good EV to EBITDA
8.13
Growth
-32.90 %
Trailing Twelve Months EV to EBITDA
Period Ending - Dec-23
Excellent EV to EBITDA
4.95
EV to EBITDA Analysis of Novo Nordisk A/S
EV to EBITDA Ratio of NVO drastically fell by -32.90 % this year. |
EV to EBITDA Ratio with value of 10.89 was highest in Year Dec-19 in last Five Years. |
EV to EBITDA Ratio of NVO trending down for at least three Years. |
Latest EV to EBITDA Ratio with value of 5.46 is lower than Average EV to EBITDA of 8.95 in last five years. |
Other EV to EBITDA Related Info of NVO that may interest you.
Novo Nordisk A/S Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
NVO | 135.28 | 132.8 | 1.87 % | Biotechnology |
Defination of Enterprise Value to EBITDA Multiple
Enterprise Value-to-EBITDA Ratio is used to compare a company's Enterprise Value to its EBITDA (Earnings before Interest, Taxes, Depreciation, and Amortization). It is useful to determine the value of a company, whether it is undervalued or overvalued. more ..EV to EBITDA Related Ratios
EBITDAMargin | EVToRevenue | PriceToEarningRatio |
Tsr Value Index
Good Value |
FY - Historical Enterprise Value to EBITDA Multiple of Novo Nordisk A/S
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
EV to EBITDA | 5.46 | 8.13 | 9.85 | 10.43 | 10.89 | 12.41 | 12.58 |
Change | -32.90 % | -17.46 % | -5.53 % | -4.29 % | -12.24 % | -1.29 % | -3.79 % |
FY Chart of Enterprise Value to EBITDA Multiple of Novo Nordisk A/S
Note : All Data Generated at the End of Trading Hours (EOD Data)